Monoclonal antibody specific for IDH1 R132H mutation

被引：335

作者：

Capper, David ^{[1
]}

Zentgraf, Hanswalter ^{[2
]}

Balss, Joerg ^{[3
]}

Hartmann, Christian ^{[1
,3
]}

von Deimling, Andreas ^{[1
,3
]}

机构：

[1] Heidelberg Univ, Dept Neuropathol, Inst Pathol, D-69120 Heidelberg, Germany

[2] German Canc Res Ctr, Monoclonal Antibody Unit, D-69120 Heidelberg, Germany

[3] German Canc Res Ctr, Clin Cooperat Unit Neuropathol G380, D-69120 Heidelberg, Germany

来源：

ACTA NEUROPATHOLOGICA | 2009年 / 118卷 / 05期

关键词：

IDH1; Monoclonal antibody; Immunohistochemistry; Astrocytoma; Oligodendroglioma; Oligoastrocytoma; CODON; 132; MUTATION; GLIOMAS;

D O I：

10.1007/s00401-009-0595-z

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

IDH1 R132H mutations occur in approximately 70% of astrocytomas and oligodendroglial tumors. We developed a mouse monoclonal antibody targeting the IDH1 R132H mutation. Here, we show the high specificity and sensitivity of this antibody on Western blots and tissue sections from formalin fixed paraffin embedded tumor specimens. This antibody is highly useful for tumor classification, in detecting single infiltrating tumor cells and for the characterization of the cellular role of mutant IDH1 protein.

引用

页码：599 / 601

页数：3

共 50 条

[31] Isocitrate dehydrogenase 1 R132H mutation is not detected in angiocentric glioma
Raghunathan, Aditya
Olar, Adriana
Vogel, Hannes
Parker, John R.
Coventry, Susan C.
Debski, Robert
Albarracin, Constance T.
Aldape, Kenneth D.
Cahill, Daniel P., III
Powell, Suzanne Z.
Fuller, Gregory N.
ANNALS OF DIAGNOSTIC PATHOLOGY, 2012, 16 (04) : 255 - 259
[32] Analysis of the IDH1 codon 132 mutation in brain tumors
Balss, Joerg
Meyer, Jochen
Mueller, Wolf
Korshunov, Andrey
Hartmann, Christian
von Deimling, Andreas
ACTA NEUROPATHOLOGICA, 2008, 116 (06) : 597 - 602
[33] Analysis of the IDH1 codon 132 mutation in brain tumors
Jörg Balss
Jochen Meyer
Wolf Mueller
Andrey Korshunov
Christian Hartmann
Andreas von Deimling
Acta Neuropathologica, 2008, 116 : 597 - 602
[34] IDH1 R132H predicts sensitivity to Bcl-xL inhibition-mediated programmed cell death
Karpel-Massler, Georg
Ishida, Chiaki Tsuge
Siegelin, Markus D.
ONCOTARGET, 2018, 9 (01) : 1 - 2
[35] Generation of a novel monoclonal antibody WMab-1 specific for IDH2-R172W mutation
Kato, Yukinari
Kaneko, Mika Kato
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2013, 433 (04) : 374 - 378
[36] Determining IDH-Mutational Status in Gliomas Using IDH1-R132H Antibody and Polymerase Chain Reaction
Gondim, Dibson D.
Gener, Melissa A.
Curless, Kendra L.
Cohen-Gadol, Aaron A.
Hattab, Eyas M.
Cheng, Liang
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2019, 27 (10) : 722 - 725
[37] Immunohistochemistry using monoclonal antibody MsMab-2 is useful to detect IDH1 R132L in intrahepatic cholangiocarcinoma
Hayashi, Akimasa
Misumi, Kento
Shibahara, Junji
Kokudo, Norihiro
Kato, Yukinari
Fukayama, Masashi
PATHOLOGY INTERNATIONAL, 2016, 66 (10) : 578 - 582
[38] Expression of R132H Mutational IDH1 in Human U87 Glioblastoma Cells Affects the SREBP1a Pathway and Induces Cellular Proliferation
Zhu, Jian
Cui, Gang
Chen, Ming
Xu, Qinian
Wang, Xiuyun
Zhou, Dai
Lv, Shengxiang
Fu, Linshan
Wang, Zhong
Zuo, Jianling
JOURNAL OF MOLECULAR NEUROSCIENCE, 2013, 50 (01) : 165 - 171
[39] IDH-1R132H mutation status in diffuse glioma patients: implications for classification
Wang, Peng-fei
Liu, Ning
Song, Hong-wang
Yao, Kun
Jiang, Tao
Li, Shou-wei
Yan, Chang-Xiang
ONCOTARGET, 2016, 7 (21) : 31393 - 31400
[40] Mutation-specific IDH1 antibody differentiates oligodendrogliomas and oligoastrocytomas from other brain tumors with oligodendroglioma-like morphology
Capper, David
Reuss, David
Schittenhelm, Jens
Hartmann, Christian
Bremer, Juliane
Sahm, Felix
Harter, Patrick N.
Jeibmann, Astrid
von Deimling, Andreas
ACTA NEUROPATHOLOGICA, 2011, 121 (02) : 241 - 252

← 1 2 3 4 5 →